Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$300,000.00
Oct 1, 2011
-
-
Translational Development Program For Analogues of EPI-001 (PNG01-185) Compounds For the Treatment of Advanced Prostate Cancer
$404,743.00
Oct 1, 2011
-
-
Best practices: Parent/provider interactions in pediatrics
$434,192.00
Oct 1, 2011
-
-
Differential control of E2F transcription factors by pRB in normal and cancer cells
$198,953.00
Oct 1, 2011
-
-
Role of Xin, an actin-binding protein, in satellite cells and muscular dystrophies
$756,990.00
Oct 1, 2011
-
-
The promyelocytic leukemia protein and nuclear domain function in DNA damage signalling and tumour suppression
$618,440.00
Oct 1, 2011
-
-
Role of Cytochrome P450-dependent Arachidonic Acid Metabolites in Hypertrophy and Heart Failure
$427,393.00
Oct 1, 2011
-
-
Efficacité des traitements pour la vestibulodynie provoquée: un essai clinique randomisé comparant la physiothérapie multimodale et l'application de lidocaïne topique
$318,945.00
Oct 1, 2011
-
-
A DNA-Based Universal Seasonal Influenza Vaccine Phase I Safety and Immunogenicity Study
$1,435,273.00
Oct 1, 2011
-
-
Addressing community concerns about health risks from Helicobacter pylori infection in Northern Canada
$85,000.00
Oct 1, 2011
-
-
Practice Pattern Variation in Discontinuing Mechanical Ventilation in Critically Ill Adults: An International Study.